Latest Interviews
Showing 1–6 of 6 transcripts.
Clear all filtersAnthropic Buys Compute From Elon & Commits $200BN to Google | Cerebras IPO | Ramp Raises at $40BN
Elon, Jason Lemkin, Rory O'Driscoll, Harry Stebbings
Anthropic enforced a board-approval mandate on all secondary share transfers to secure cap table integrity ahead of an IPO, a move that triggered market volatility and reshaped liquidity expectations for its investors. Concurrently, the company solidified its strategic position through a $200 billion Google partnership and a compute capacity deal with SpaceX, while the broader market witnessed high-profile IPOs like Cerebras' record oversubscription alongside significant SaaS valuation resets driven by divergent growth trajectories. These developments underscore a sector-wide shift toward infrastructure consolidation and rigorous performance metrics, where success now hinges on tangible AI integration and the ability to navigate complex legal and competitive landscapes.
- All-In Podcast1h 21m
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
Elon, Sam, Friedberg, Jason Calacanis, David Sacks, Chamath Palihapitiya
OpenAI faces mounting structural tensions as it misses 2025 revenue and user targets while CEO Sam Altman pushes for an IPO against CFO Sarah Fryer's caution amidst $600 billion in future compute commitments. The company currently maintains a compute advantage over rivals like Anthropic through excess data center capacity, even as the broader AI sector grapples with power grid bottlenecks and a record $725 billion in hyperscaler capital expenditures for 2026. Concurrently, Elon Musk pursues a $150 billion lawsuit alleging a breach of charitable trust following internal documents revealing plans to remove him before the entity's conversion to for-profit status.
- All-In Podcast1h 30m
Trump Rally or Bessent Put? Elon Back at Tesla, Google's Gemini Problem, China's Thorium Discovery
Trump, Bessent, Elon, Andrew Ross Sorkin, Chamath, Jason, Friedberg
A panel of experts analyzes global market dynamics, noting that recent rallies stem from trade deal expectations rather than Federal Reserve support, while highlighting strategic tensions over China's control of rare earths and its lead in thorium energy research. The discussion extends to foreign policy, where participants advocate for accepting the Istanbul Deal to end the Ukraine war and criticizing the moralistic approach to nation-building. Finally, the group evaluates corporate strategies for Alphabet and Tesla, the fiscal hurdles facing the Department of Government Efficiency, and the regulatory complexities surrounding Nvidia's global supply chain.
- All-In Podcast1h 7m
E144: Biden targets Elon, BRICS challenges the West, Tiger hit piece & more
Biden, Elon, Chamath, Tiger Global, Sacks, India
The hosts recount an exhaustive six-day poker marathon in Puerto Vallarta featuring Kevin Hart, alongside a viral social media debate sparked by Chamath Palihapitiya's "Man in the Arena" critique of anonymous critics. The discussion then pivots to US government investigations targeting Elon Musk's companies and President Biden's business dealings, while analyzing shifting Republican primary dynamics and the geopolitical impact of BRICS expansion. Finally, the group previews the upcoming All-In Summit's themed parties and evaluates US nuclear energy capabilities in the context of global competition with China and India.
- All-In Podcast1h 28m
E59: Twitter's content warning algo, equity audits, politicians trading stocks, Fed's next move
Elizabeth Warren, Elon, Jeremy Strong, London Breed, Jason Calacanis, David Sacks
In a recent episode of the "All In" podcast, Chamath Palihapitiya, David Sacks, and their co-hosts address the Federal Reserve's accelerated tapering plan while critiquing House Democrats' proposed racial equity audits as paternalistic grifts that threaten innovation. The panelists also analyze Omicron's high transmissibility against lower severity, predicting a political shift away from strict lockdowns as the pandemic becomes endemic, and discuss the burgeoning mainstream potential of mRNA technology for treating cancer. Furthermore, the discussion covers emerging tensions in tech moderation, bipartisan failures in congressional insider trading enforcement, and the potential for a "red wave" in the 2022 midterms driven by voter fatigue with radical progressive policies.
- All-In Podcast1h 23m
E32: Behind the scenes of Elon hosting SNL, CDC failures, America's real-time UBI experiment & more
Elon, Chamath, Calacanis, Friedberg, Jason, Stanley Druckenmiller, David Sacks
David Sacks detailed Elon Musk's culturally impactful *SNL* appearance and a viral monologue joke, while also criticizing CDC guidance on outdoor transmission and alleging political collusion with teachers' unions. Macroeconomic analysts Stanley Druckenmiller and Sacks condemned federal overstimulation and California's misallocated surpluses as drivers of inflation and labor shortages. The conversation further explored a potential "Netscape moment" for synthetic biology, highlighting breakthroughs in stem cell therapy and nitrogen-fixing microbes alongside critiques of traditional media's declining influence.